ePrints@IIScePrints@IISc Home | About | Browse | Latest Additions | Advanced Search | Contact | Help

2D-MoS2-based β-lactamase inhibitor for combination therapy against drug-resistant bacteria

Ali, SR and Pandit, S and De, M (2018) 2D-MoS2-based β-lactamase inhibitor for combination therapy against drug-resistant bacteria. In: ACS Applied Bio Materials, 1 (4). pp. 967-974.

[img] PDF
ACS_app_bio_mat_1-4_967-974_2018.pdf - Published Version
Restricted to Registered users only

Download (3MB) | Request a copy
supplementary_ACS_app_bio_mat_1-4_967-974_2018.pdf - Published Supplemental Material

Download (771kB) | Preview
Official URL: https://doi.org/10.1021/acsabm.8b00105


Despite the remarkable improvement in modern medicine, the ever-increasing abundance of antibiotic-resistant microorganisms remains a catastrophic threat to global health care. β-Lactamase is playing one of the major roles in antibiotic resistance by making the conventional antibacterial agents abortive by destroying their lactam ring. The combination therapy of traditional antibiotics along with β-lactamase inhibitors is a potential solution to this problem. In this work, we have screened various functionalized two-dimensional molybdenum disulfide (2D-MoS2) nanomaterials as enzyme inhibitors that effectively bind with β- lactamase enzyme and reveal competitive inhibition. Among these, carboxylate-functionalized negatively charged 2D-MoS2 is the most potent inhibitor, and in vitro combinatorial application of this with conventional antibiotics has been able to remarkably suppress relevant drug-resistant bacterial growth rate. This study will help to further explore different surface-functionalized 2D nanomaterials with improved β-lactamase inhibition to fight against multidrug-resistant bacterial infections.

Item Type: Journal Article
Publication: ACS Applied Bio Materials
Publisher: American Chemical Society
Additional Information: The copyright for this article belongs to the American Chemical Society.
Keywords: Antibiotics; Carboxylation; Drug therapy; Enzyme inhibition; Health risks; Layered semiconductors; Molybdenum compounds; Nanostructured materials; Sulfur compounds, Anti-bacterial activity; Combination therapy; Functionalized; Lactamases; Multidrug resistants, Bacteria
Department/Centre: Division of Chemical Sciences > Organic Chemistry
Date Deposited: 05 Aug 2022 05:51
Last Modified: 05 Aug 2022 05:51
URI: https://eprints.iisc.ac.in/id/eprint/75202

Actions (login required)

View Item View Item